Cancer cells and stromal cells cooperate by exchanging diffusible factors that sustain tumor growth, a form of frequency-dependent selection that can be studied in the framework of evolutionary game theory. In the case of multiple myeloma, three types of cells (malignant plasma cells, osteoblasts and osteoclasts) exchange growth factors with different effects, and tumor-stroma interactions have been analysed using a model of cooperation with pairwise interactions. Here we show that a model in which growth factors have autocrine and paracrine effects on multiple cells, a more realistic assumption for tumor-stroma interactions, leads to different results, with implications for disease progression and treatment. In particular, the model reveal...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
It is clear that cancers comprise a mixture of clones, a feature termed intra-clonal heterogeneity, ...
Currently, multiple myeloma is the second most common hematological malignancy in the U.S., constitu...
Cancer cells and stromal cells often exchange growth factors with paracrine effects that promote cel...
Cancer cells and stromal cells often exchange growth factors with paracrine effects that promote cel...
Preventing relapse is the major challenge to effective therapy in cancer. Within the tumour, stromal...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
In the thesis we focus on multiple myeloma bone disease. In this cancer three types of cells are pre...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is ch...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Tumours are made up of a mixed population of different types of cells that include normal structures...
International audienceThe standard model of multiple myeloma (MM) relies on genetic instability in t...
Anti-cancer therapies promote clonal selection of resistant cells that evade treatment. Effective th...
The development of a cancerous tumor requires affected cells to collectively display an assortment o...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
It is clear that cancers comprise a mixture of clones, a feature termed intra-clonal heterogeneity, ...
Currently, multiple myeloma is the second most common hematological malignancy in the U.S., constitu...
Cancer cells and stromal cells often exchange growth factors with paracrine effects that promote cel...
Cancer cells and stromal cells often exchange growth factors with paracrine effects that promote cel...
Preventing relapse is the major challenge to effective therapy in cancer. Within the tumour, stromal...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
In the thesis we focus on multiple myeloma bone disease. In this cancer three types of cells are pre...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is ch...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Tumours are made up of a mixed population of different types of cells that include normal structures...
International audienceThe standard model of multiple myeloma (MM) relies on genetic instability in t...
Anti-cancer therapies promote clonal selection of resistant cells that evade treatment. Effective th...
The development of a cancerous tumor requires affected cells to collectively display an assortment o...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
It is clear that cancers comprise a mixture of clones, a feature termed intra-clonal heterogeneity, ...
Currently, multiple myeloma is the second most common hematological malignancy in the U.S., constitu...